Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia

A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Douglas J. Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas Rex

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.Am J Gastroenterol advance online publication, 18 October 2016; doi:10.1038/ajg.2016.492.

Original languageEnglish (US)
JournalAmerican Journal of Gastroenterology
DOIs
StateAccepted/In press - Oct 18 2016

Fingerprint

Occult Blood
Hematologic Tests
Advisory Committees
Early Detection of Cancer
Colorectal Neoplasms
Publications
Neoplasms
Hemoglobins
Guidelines

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia : A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. / Robertson, Douglas J.; Lee, Jeffrey K.; Boland, C. Richard; Dominitz, Jason A.; Giardiello, Francis M.; Johnson, David A.; Kaltenbach, Tonya; Lieberman, David; Levin, Theodore R.; Rex, Douglas.

In: American Journal of Gastroenterology, 18.10.2016.

Research output: Contribution to journalArticle

Robertson, Douglas J. ; Lee, Jeffrey K. ; Boland, C. Richard ; Dominitz, Jason A. ; Giardiello, Francis M. ; Johnson, David A. ; Kaltenbach, Tonya ; Lieberman, David ; Levin, Theodore R. ; Rex, Douglas. / Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia : A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. In: American Journal of Gastroenterology. 2016.
@article{5a224bc88f684ab2b539e7c3f1cc0dd4,
title = "Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer",
abstract = "The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.Am J Gastroenterol advance online publication, 18 October 2016; doi:10.1038/ajg.2016.492.",
author = "Robertson, {Douglas J.} and Lee, {Jeffrey K.} and Boland, {C. Richard} and Dominitz, {Jason A.} and Giardiello, {Francis M.} and Johnson, {David A.} and Tonya Kaltenbach and David Lieberman and Levin, {Theodore R.} and Douglas Rex",
year = "2016",
month = "10",
day = "18",
doi = "10.1038/ajg.2016.492",
language = "English (US)",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia

T2 - A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

AU - Robertson, Douglas J.

AU - Lee, Jeffrey K.

AU - Boland, C. Richard

AU - Dominitz, Jason A.

AU - Giardiello, Francis M.

AU - Johnson, David A.

AU - Kaltenbach, Tonya

AU - Lieberman, David

AU - Levin, Theodore R.

AU - Rex, Douglas

PY - 2016/10/18

Y1 - 2016/10/18

N2 - The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.Am J Gastroenterol advance online publication, 18 October 2016; doi:10.1038/ajg.2016.492.

AB - The use of the fecal occult blood test (FOBT) for colorectal cancer (CRC) screening is supported by randomized trials demonstrating effectiveness in cancer prevention and widely recommended by guidelines for this purpose. The fecal immunochemical test (FIT), as a direct measure of human hemoglobin in stool has a number of advantages relative to conventional FOBT and is increasingly used relative to that test. This review summarizes current evidence for FIT in colorectal neoplasia detection and the comparative effectiveness of FIT relative to other commonly used CRC screening modalities. Based on evidence, guidance statements on FIT application were developed and quality metrics for program implementation proposed.Am J Gastroenterol advance online publication, 18 October 2016; doi:10.1038/ajg.2016.492.

UR - http://www.scopus.com/inward/record.url?scp=84991706700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991706700&partnerID=8YFLogxK

U2 - 10.1038/ajg.2016.492

DO - 10.1038/ajg.2016.492

M3 - Article

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

ER -